SEC Form 20-F - Deutsche Bank Annual Report 2012
SEC Form 20-F - Deutsche Bank Annual Report 2012
SEC Form 20-F - Deutsche Bank Annual Report 2012
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Deutsche</strong> <strong>Bank</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>20</strong>10 on <strong>Form</strong> <strong>20</strong>-F<br />
Item 11: Quantitative and Qualitative Disclosures about Credit, Market and Other Risk 153<br />
The volume of our consumer credit exposure increased due to the consolidation of Postbank by € 75.3 billion<br />
or 89 %, mainly in German mortgage lending. As loans were consolidated at their fair values representing our<br />
expected future cash flows, no consolidated loans were considered 90 days or more past due as of December<br />
31, <strong>20</strong>10. The net credit cost incurred on Postbank consumer credit loans since consolidation date were insignificant<br />
compared to the consolidated loan volume. The volume of our consumer credit exposure excluding<br />
Postbank rose by € 4 billion, or 4.5 %, from year end <strong>20</strong>09 to December 31, <strong>20</strong>10, driven by volume growth in<br />
Germany (up € 902 million), Poland (up € 1,034 million), Italy (up € 949 million) and Portugal (up € 547 million),<br />
mainly within mortgage lending. Measures taken on portfolio and country level lead to significant reduction of<br />
net credit costs in Spain and India, partially offset by increases in our consumer finance business in Poland.<br />
Revised parameter and model assumptions in <strong>20</strong>09 led to a one-time release of loan loss allowance of<br />
€ 60 million in the first quarter <strong>20</strong>09 as well as a lower level of provisions for credit losses of € 28 million for the<br />
first quarter <strong>20</strong>10.<br />
Credit Exposure from Derivatives<br />
The following table shows the notional amounts and gross market values of OTC and exchange-traded derivative<br />
contracts we held for trading and nontrading purposes as of December 31, <strong>20</strong>10. The table below includes<br />
Postbank OTC and exchange-traded derivative contracts which have a negligible impact on the overall totals.<br />
Dec 31, <strong>20</strong>10 Notional amount maturity distribution Positive<br />
in € m. Within 1 year<br />
> 1 and<br />
≤ 5 years After 5 years Total<br />
Exchange-traded derivative transactions (e.g., futures and options) are regularly settled through a central<br />
counterparty (e.g., LCH. Clearnet Ltd. or Eurex Clearing AG), the rules and regulations of which provide for<br />
daily margining of all current and future credit risk positions emerging out of such transactions. To the extent<br />
possible, we also use central counterparty clearing services for OTC derivative transactions (“OTC clearing”);<br />
we thereby benefit from the credit risk mitigation achieved through the central counterparty’s settlement system.<br />
market<br />
value<br />
Negative<br />
market<br />
value<br />
Net<br />
market<br />
value<br />
Interest-rate-related transactions:<br />
OTC products 16,942,302 15,853,777 11,080,457 43,876,536 419,196 401,179 18,017<br />
Exchange-traded products 1,1<strong>20</strong>,579 276,258 2,272 1,399,109 128 110 18<br />
Sub-total 18,062,881 16,130,035 11,082,729 45,275,645 419,324 401,289 18,035<br />
Currency-related transactions:<br />
OTC products 3,805,544 1,325,473 607,743 5,738,760 110,440 118,452 (8,012)<br />
Exchange-traded products 13,113 970 – 14,083 104 221 (117)<br />
Sub-total 3,818,657 1,326,443 607,743 5,752,843 110,544 118,673 (8,129)<br />
Equity/index-related transactions:<br />
OTC products 362,294 333,108 95,785 791,187 31,084 38,297 (7,213)<br />
Exchange-traded products 256,942 100,475 4,332 361,749 2,933 1,995 938<br />
Sub-total 619,236 433,583 100,117 1,152,936 34,017 40,292 (6,275)<br />
Credit derivatives 308,387 2,545,673 537,759 3,391,819 81,095 73,036 8,059<br />
Other transactions:<br />
OTC products 143,323 150,068 8,831 302,222 18,587 17,879 708<br />
Exchange-traded products 72,437 41,874 839 115,150 2,742 2,621 121<br />
Sub-total 215,760 191,942 9,670 417,372 21,329 <strong>20</strong>,500 829<br />
Total OTC business 21,561,850 <strong>20</strong>,<strong>20</strong>8,099 12,330,575 54,100,524 660,402 648,843 11,559<br />
Total exchange-traded business 1,463,071 419,577 7,443 1,890,091 5,907 4,947 960<br />
Total 23,024,921 <strong>20</strong>,627,676 12,338,018 55,990,615 666,309 653,790 12,519<br />
Positive market values including<br />
the effect of netting and cash<br />
collateral received 63,942